There are multiple ways that we can help our patients reduce the risk of overdose. In our interview with Dr. Aaron Quiggle, we cover screening, fentanyl testing, the use of Narcan and the importance of learning to prescribe buprenorphine.

One of the most challenging problems in adolescent care is figuring out what level of care will give patients the best chance of recovery or progress. We give you a guide to decide what level of care to recommend based on your individual patient.

Most of us use methylphenidate (MPH) routinely in patients across a wide range of ages and even diagnoses. But what are the long-term side effects of MPH? This research update gives you a current understanding of the potential risks with helpful guidance on how to proceed with care.

We are understandably hesitant to treat young children with medication for ADHD. Does it work? Will there be worse or different side effects? This research update will help you weigh the risks and benefits of pursuing stimulant treatment for ADHD in our smallest patients.

Mental health problems in young children are incredibly complex. Dr. Jeffrey Rowe’s comprehensive outline helps us organize our assessment and care planning for these children. Even more important, since most of us see older kids, Dr. Rowe helps us find the links between problems in early childhood and later mental health challenges.

We all want to offer comprehensive care that includes every team member: therapists, teachers, parents, and even the child. This is a daunting task, and our clinical update gives you the reasoning to share and the ideas you can use to pursue this ideal with your patients and their families.

Pathological demand avoidance (PDA) is a popular concern among autistic kids and families. It’s not in the DSM, yet we need to understand and address it. This clinical update helps you approach irritability and PDA rationally to help autistic patients connect and regulate before merely prescribing D2-blocking antipsychotics.